Synnovation Therapeutics

About | SynnovationTx

Synnovation Therapeutics was founded in 2021, is headquartered in Wilmington, United States, lists 11–50 employees, and has $102.0M in recorded funding across 1 round.

Headquarters
Wilmington
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$102.0M
Last Round
$102.0M Series AJan 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Synnovation Therapeutics is a Wilmington, Delaware-based precision medicine company founded in 2021 by a world-class medicinal chemistry team from Incyte, where the founders previously contributed to the discovery of five approved drugs including Jakafi, Olumiant, Pemazyre, Tabrecta, and Opzelura. The company develops small-molecule targeted therapies optimized for best-in-class pharmacology against highly validated oncology targets. Its lead program, SNV1521, is a CNS-penetrant PARP1 inhibitor now in a Phase I study, and its second program targets oncogenic PI3K-alpha mutations. Synnovation launched publicly in January 2024 with a $102 million Series A led by Third Rock Ventures.

Summary

Synnovation Therapeutics is a Biotech company based in Wilmington, United States, founded in 2021. It lists 11–50 employees. It has raised $102.0M in total across 1 round, most recently a $102.0M Series A round in Jan 2024. Investors include Third Rock Ventures, Nextech Invest and Lilly Asia Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2024
$102.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Synnovation Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/synnovation-therapeutics"><img src="https://indexed.vc/api/badge/company/synnovation-therapeutics" alt="Synnovation Therapeutics on Indexed.vc" width="260" height="76" /></a>